3[3]Leszczyniecka M,Roberts T,Dent P,et al.Differentiation therapy of human cancer:basic science and clinical applications.Pharmacol Ther,2001,90:105-156.
4[4]Huang WW,Yang JS,Lin CF,et al.Pycnogenol induces differentiation and apoptosis in human promyeloid leukemia HL-60 cells.Leukemia Research,2005,29:685-692.
5[5]Sell S.Stem cell origin of cancer and differentiation therapy.Chit Rev oncol Hematol,2004,51:1-28.
7[7]Joseph Lotem,Leo Sachs.Epigenetios wins over genetics:induction of differentiation in tumor cells.Cancer Biology,2002,12:339-346.
8[8]Montenegro RC,Vasconcelios MC,Bezerra FS,et al.Pisusterol induces monocytic differentiation in HL-60 cells.Toxicology in Vitro,2007,21:795-800.
9[9]Ricand S,Venrus B,Bounieu A.Response of human rhabdomyosarcoma cell lines to retinoic acid:Relationship with induction of differentiation and retinoic acid sensitivity.Experimental Cell Research,2005,311:192-204.
10[10]Barber N,Belor L,Richard 1,et al.AIl-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeioid leulaemias,Leukemia Research,2007:1-8.
7[1]Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapy of human cancer: basic science and clinical applications[J]. Pharmacol Ther, 2001,90(2-3): 105-156.
8[3]Basak R, Basu M, Chatterjee M. Combined supplementation of vanadium and lalpha, 25-dihydroxyvitamin D (3) inhibit diethylnitrosamine-induced rat liver carcinogenesis [J]. Chem Biol Interact,2000,128(1):1-18.
9[4]Ortiz MA, Bayou Y, Lopez-Hernandez FJ, et al. Retinoids in combination therapies for the treatment of cancer:mechanisms and perspectives [J]. Drug Resist Updat,2002,5 (3-4): 162-175.
10[6]Desai SH, Boskovic G, Eastham L, et al. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells [J]. Biochem Pharmacol,2000,59(10): 1265-1275.
